Drug Interaction Report

Granisetron Transdermal Patch and Lopinavir: Interaction Details

Name: Granisetron Transdermal Patch and Lopinavir Interaction
Creator: Dr. Brian Staiger, PharmD, BCPS

A pharmacist-reviewed analysis of the Granisetron Transdermal Patch and Lopinavir interaction: the documented clinical effects, severity rating, onset, mechanism, and management considerations, with cited references throughout.

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Granisetron Transdermal Patch

Sancuso Sancuso®

Lopinavir

No brand names on record

Medically reviewed by

Dr. Brian Staiger, PharmD, BCPS

Updated Aug 8, 2026

Editorial policy · Data sources

Interaction severity

Major

Potentially serious — often needs a change or close monitoring.

Minor

Moderate

Major

Contraindicated

How we grade severity & evidence

Severity levels

Contraindicated: These should generally not be used together.
Major: Potentially serious — often needs a change or close monitoring.
Moderate: Can be significant — usually manageable with monitoring.
Minor: Usually limited clinical impact.

Evidence grades

Established: Well documented — supported by controlled studies or strong clinical data.
Probable: Good supporting evidence, though not definitively proven.
Suspected: Some evidence suggests this interaction, but it is not well established.
Possible: Limited or conflicting evidence; the interaction may occur.
Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 281 documented Granisetron Transdermal Patch interactions, 265 are rated major — including this one.

Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.

Onset

unspecified

Evidence

theoretical

Severity

Major

What happens

An increased risk of QT interval prolongation

Interaction Deep Dive

Postmarketing cases of QT interval prolongation and torsade de pointes have been reported with lopinavir/ritonavir. Due to the potential for additive effects on the QT interval and increased risk of torsade de pointes, avoid the concomitant use of lopinavir/ritonavir with other drugs that prolong the QT interval², such as granisetron ¹. If concurrent therapy is required, monitor carefully for QT interval prolongation.

Why it happens (mechanism)

Additive effects on QT interval prolongation

Common questions

Can I take Granisetron Transdermal Patch and Lopinavir together?

An increased risk of QT interval prolongation Always confirm with your pharmacist or prescriber before making any change.

How serious is the Granisetron Transdermal Patch and Lopinavir interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

Does my dose of Granisetron Transdermal Patch or Lopinavir need adjusting while I take them together?
What symptoms should prompt me to call you or my prescriber right away?
Does the timing of my doses matter for this combination?
Is there a safer alternative to one of these medications for me?

References (2)

Product Information: KYTRIL(R) IV injection, granisetron HCl IV injection. Genentech USA, Inc, South San Francisco, CA, 2011.
Product Information: KALETRA oral tablets, oral solution, lopinavir and ritonavir oral tablets, oral solution. Abbott Laboratories, North Chicago, IL, 2011. DailyMed

Was this write-up helpful?

Granisetron Transdermal Patch

Keep reading about Granisetron Transdermal Patch

All Granisetron Transdermal Patch interactions (281) Granisetron Transdermal Patch drug information

Also serious with: Phenelzine Pimozide Piperaquine Saquinavir

Lopinavir

Keep reading about Lopinavir

All Lopinavir interactions (94)

Also serious with: Dihydroergotamine Injection Lovastatin Methylergonovine Ketoconazole Topical

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

A message from HelloPharmacist

About our interaction database: depth, not breadth

HelloPharmacist doesn't license one of the big commercial interaction databases, so what you'll find here is not a complete list of every known drug interaction. Instead, each entry is researched, analyzed, and written up individually — documented from the published literature, reviewed by a pharmacist, and cited so you can check every source yourself.

If a combination isn't listed here, it means we haven't documented it yet — never that it's safe. For screening a full medication list, we recommend pairing this site with a comprehensive tool like the Drugs.com Interaction Checker and, most importantly, a review by your own pharmacist. For a deep, plain-English, fully sourced explanation of a specific documented interaction — that's exactly what we built this for.

This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.